©2020 AEA3 WEB
Image default
News

Moderna Covid vaccine candidate almost 95% effective, trials show

US-based biotech firm is latest to reveal impressive results from phase 3 trials of jab

  • Coronavirus – latest updates
  • See all our coronavirus coverage

The race for a coronavirus vaccine has received another shot in the arm with the US biotech firm Moderna becoming the latest to reveal impressive results from phase 3 trials of its jab.

An interim analysis released on Monday, and based on 95 patients with confirmed Covid infections, found the candidate vaccine has an efficacy of 94.5%. The company said it now plans to apply to the US regulator, the Food and Drug Administration, for emergency-use authorisation in the coming weeks. In the trial, 90 of the patients received the placebo with the remaining five the vaccine.

Continue reading…

Related posts

F1 Turkish Grand Prix: Lewis Hamilton bids for seventh world title – live!

AEA3

Girl, 14, arrested in West Sussex murder inquiry

AEA3

Tariq Ali spied on by at least 14 undercover officers, inquiry hears

AEA3

Your ads here. Click here